“…32,33 However, transient Hh activation in salivary glands, such as overexpression of Gli1 transgene for 15 weeks and overexpression of Shh transgene for 1 week, did not result in any detectable tumor in mice. 15,34 Gene therapy for salivary gland hypofunction has several unique advantages, including easy access to most parenchymal cells via duct cannulation, the capacity to produce high amounts of protein, and tight encapsulation that minimizes concern about transgene spread. 35 We reported earlier that in wild-type mice with subcutaneous head and neck squamous cell carcinoma, the delivery of Ad-Shh to SMGs by retrograde ductal instillation efficiently activated the Hh/Gli pathway in SMGs, but did not activate the Hh/Gli pathway in tumors and did not affect the growth and response to radiotherapy of tumors, 15 indicating that local Hh activation in salivary glands will not promote the growth and radioresistance of preexisting tumors outside salivary glands.…”